Brain Cell Senescence: A New Therapeutic Target for the Acute Treatment of Ischemic Stroke

Abstract Aging is a major risk factor for cerebral infarction. Since cellular senescence is intrinsic to aging, we postulated that stroke-induced cellular senescence might contribute to neural dysfunction. Adult male Wistar rats underwent 60-minute middle cerebral artery occlusion and were grouped a...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuropathology and experimental neurology Vol. 81; no. 8; pp. 614 - 620
Main Authors Baixauli-Martín, Júlia, Aliena-Valero, Alicia, Castelló-Ruiz, María, Burguete, María C, López-Morales, Mikahela A, Muñoz-Espín, Daniel, Torregrosa, Germán, Salom, Juan B
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Aging is a major risk factor for cerebral infarction. Since cellular senescence is intrinsic to aging, we postulated that stroke-induced cellular senescence might contribute to neural dysfunction. Adult male Wistar rats underwent 60-minute middle cerebral artery occlusion and were grouped according to 3 reperfusion times: 24 hours, 3, and 7 days. The major biomarkers of senescence: 1) accumulation of the lysosomal pigment, lipofuscin; 2) expression of the cell cycle arrest markers p21, p53, and p16INK4a; and 3) expression of the senescence-associated secretory phenotype cytokines interleukin-6 (IL-6), tumor necrosis factor α (TNF-α), and interleukin-1β (IL-1β) were investigated in brain samples. Lipofuscin accumulation was scarce at the initial stage of brain damage (24 hours), but progressively increased until it reached massive distribution at 7 days post-ischemia. Lipofuscin granules (aggresomes) were mainly confined to the infarcted areas, that is parietal cortex and adjacent caudate-putamen, which were equally affected. The expression of p21, p53, and p16INK4a, and that of IL-6, TNF-α, and IL-1β, was significantly higher in the ischemic hemisphere than in the non-ischemic hemisphere. These data indicate that brain cell senescence develops during acute ischemic infarction and suggest that the acute treatment of ischemic stroke might be enhanced using senolytic drugs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3069
1554-6578
DOI:10.1093/jnen/nlac048